Phibro Animal Health Corporation (PAHC) Stock Grade

About Phibro Animal Health Corporation's fundamentals

Phibro Animal Health is generating strong top-line momentum with revenue growth of 27.4% year-over-year, though profitability remains modest with a net margin of 3.7%. The company is delivering solid returns to shareholders, evidenced by a return on equity of 16.9%, while trading at a P/E ratio of 21.4. With a market capitalization of $1.0 billion and a dividend yield of 1.9%, the company is returning capital to investors while maintaining operational growth in the specialty and generic animal health drug market.